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ABSTRACTS1390: ASSESSING THE VALIDITY OF THE PCPT AND ERSPC RISK CALCU-
LATORS FOR PROSTATE CANCER IN A COHORT OF THE POPULATION AT
HIGHEST RISK OF PROSTATE CANCER IN EUROPE
Dara Lundon 1, Brian Kelly 3, William Watson 4, John Fitzpatrick 2,
David Quinlan 1, Killian Walsh 3, David Galvin 1. 1 St.Vincents University
Hospital, Dublin, Ireland; 2Mater Misericordiae University Hospital, Dublin,
Ireland; 3University Hospital Galway, Galway, Ireland; 4Conway Institute of
Biomedical and Biomolecular Research, University College Dublin, Dublin,
Ireland.
Introduction: Prostate Cancer is the most common non-cutaneous ma-
lignancy amongst men in developed nations. Prostate biopsy(TRUS-PBx)
carries with it signiﬁcant risks. Tools exist which assess the possible
outcome of TRUS-PBx before exposing a patient to these risks. Our
objective was to assess the predictive accuracy of the Prostate Cancer
Prevention Trial Prostate Cancer Risk Calculator(PCPT-PCRC) and the Eu-
ropean Randomized Study of Screening for Prostate Cancer Risk Calculator
(ERSPC-RC) in a cohort from Ireland.
Methods: We prospectively collected relevant information on all men
undergoing a TRUS prostate biopsy. Prostate cancer diagnosis risk and high
grade disease risk were correlated with the ﬁnal biopsy histological grade,
and novel analytical techniques were utilised to assess clinical utility of
these tools.
Results: Of 800 prostate biopsies, cancer was subsequently diagnosed in
392 (49%). Of these cancer diagnoses, 192 (24 %) had high grade disease.
Correlation between Risk & PCPT-RC ERSPC-RC. Cancer diagnosis <0.05
<0.05. High Grade Disease Dx <0.05 <0.05
Conclusions: The PCPT-RC and the ERSPC-RC both demonstrate statisti-
cally signiﬁcant prediction of both prostate cancer and high grade disease
diagnoses in an Irish Cohort. Both models can be used accurately in this
cohort. However following assessment the PCPT-RC demonstrates greater
clinical utility in this cohort.
1408: SHOULD ACUTE PYELONEPHRITIS BE MANAGED UNDER
UROLOGISTS?
Rachel Darnell, Michael Shenouda, Lucy Freeman, Eleanor Winstanley,
Miranda Lewis, Olatundun Macaulay, William Dunsmuir. St Peter's
Hospital, Chertsey, UK.
Aims: Pyelonephritis is traditionally managed under the care of physi-
cians; however, in our institution it is managed primarily under urologists.
We sought to assess the proportion of patients admitted with acute py-
elonephritis requiring surgical intervention.
Methods: Prospective audit of all patients admitted with pyelonephritis or
systemic infection of urinary tract origin over 7 weeks at a DGH. Data
collected included demographics, laboratory and radiological in-
vestigations, and surgical intervention.
Results: 31 consecutive patients, with mean age 52 years (range 17-95),
and F:M ratio of 2.6:1. 42% patients had an entirely normal urinary tract
USS. 10 patients (32%) had evidence of hydronephrosis or an obstructed
system on USS or CT, of which 5 had associated impairment of renal
function. 7 patients (23%) required urgent invasive intervention (surgery,
nephrostomy), all of whom had abnormal imaging and raised inﬂamma-
tory markers; 4 also had deranged renal function. Average time to surgical
intervention, from decision to operate, was 9.6 hours.
Conclusion: Acute pyelonephritis and severe urinary sepsis can have
potentially serious complications, and may often require urgent invasive
intervention. We recommend early urological input to facilitate adequate
and timely surgical intervention where necessary. This should ensure
optimal patient care and prevention of avoidable delays to treatment.
1417: TO ASSESS THE DIFFERENCES IN ONCOLOGICAL OUTCOMES OF PA-
TIENTS WITH PT0 STAGE AFTER RADICAL CYSTECTOMY (RC) FOR URO-
THELIAL CARCINOMA OF URINARY BLADDER WITH AND WITHOUT
NEOADJUVANT CHEMOTHERAPY THERAPY (NAT)
Vijay Rao Gudla, G.M. Nandwani, N. Shaikh, N. Ragavan, S.K. Addla.
Bradford Teaching Hospital, Bradford, UK.
Introduction: NAT with RC is the standard of care for muscle invasive
bladder tumour. It has been seen that patients with high stage have better
outcomes with NAT. Oncological outcomes with and without NAT are not
well known for patients with pT0. To throw more light on this subject we
conducted a study on patients with pT0 disease.Methods:Studycohort includedpatients fromJan2006 toSept2012whohad
pT0N0M0 stage after RC and thesewere divided into 2 groups on the basis of
NAT. Progression free survival (PFS), overall survival (OS)were calculated and
complications were recorded according to Clavian grading system.
Results: There were 30 patients in the study, 14 had NAT. Median age,
hospital stay and follow-up were 64 years, 13 days and 31 months
respectively. Complications occurred in 8 (26.6%), majority being grade 1 &
2 (16.6%). Higher rate of complications occurred in NAT group (35.7%) in
comparison to non NAT group (18.75%). There were no deaths in either
group. PFS were 92.85% and 93.75% in NAT group and non NAT group.
Conclusions: Morbidity and mortality of RC with and without neo adju-
vant therapy was acceptable and OS and PFS were not different.VASCULAR / ENDOVASCULAR SURGERY
0052: A STUDY OF SMOKING CESSATION IN VASCULAR PATIENTS: ARE
WE DOING ENOUGH AND DOES IT MATTER?
G. Estebanez, D. Hunt, P. Wilson, C. Humphrys, S. Dimitri. Countess of
Chester Hospital, Chester, UK.
Purpose: Smoking is the leading risk factor for vascular disease, and
therefore smoking cessation strategies are paramount in prevention and
treatment of vascular disease. Our aim was to determine if smoking
cessation advice and treatment was provided to all smoking vascular ad-
missions, and its effectiveness.
Method: A telephone survey was performed for all vascular admissions,
within a twelve month period, to ascertain if they were a smoker, if they
received smoking cessation advice/treatment, their openness to this, and
whether they subsequently quit smoking.
Results: Of the 310 admissions, 187 were available for interview. Of these,
50 (27%) were smokers and 137 (73%) were not. 26 (52%) of the smokers
were given smoking cessation advice, and 24 of these were open to this
advice, however only 6 (23%) were started on treatment. 7 (27%) of those
given advice quit smoking, including 4 of the 6 given treatment. In com-
parison, only 3 of the 24 (12%) patients who did not receive advice/treat-
ment actually quit.
Conclusion: Smoking cessation advice and treatment is a simple but
effective means of improving prognosis and readmission rates. However,
its provision is inadequate and ore aggressive strategies are needed.
0058: RISK OF UNDERLYING MALIGNANCY IN PATIENTS AGED 60 OR
OVER WITH IDIOPATHIC VENOUS THROMBO-EMBOLISM MAY BE
MUCH HIGHER THAN CURRENT DATA SUGGESTS
Veejay Bagga, Gary Lambert, Stanley Silverman. Sandwell West Birmingham
Hospitals NHS Trust, City Hospital, Birmingham, UK.
Introduction: We investigated the risk of underlying malignancy in pa-
tients presenting with idiopathic venous thromboembolism (VTE).
Methods: A retrospective case control study into presentations of VTE to a
single NHS Trust between 2005-2008 was conducted. All diagnoses of VTE
were analysed, identifying cases of idiopathic VTE. Cases were compared to
the regional cancer registry, identifying those subsequently diagnosed
with malignancy after diagnosis of idiopathic VTE. Controls were age-sex
matched from patients presenting with symptoms of VTE but negative
duplex scan or venogram.
Results: 225 patients presented idiopathic VTE between 1st January 2005
and 31st December 2008. 16 (7.1%) were later diagnosed with malignancy,
compared with 5 (2.2%) in controls (Odds ratio 3.36, P¼<0.05). Of those in
the VTE group aged 60 or over, 15 of 112 (13.4%) subsequently developed
cancer vs 5 controls (OR 3, p<0.5). Mean case time to malignant diagnosis
was 255 days.
Conclusions: Patients aged 60 or over presenting with idiopathic VTE have
signiﬁcantly higher risk of underlying malignancy than previously re-
ported and should therefore undergo further detailed screening to look for
occult malignancy.
0059: FAST-TRACK PATHWAYS IN THE MANAGEMENT OF DEEP VENOUS
THROMBOSIS: MISSED OPPORTUNITIES IN CANCER DIAGNOSIS
Gary Lambert, Veejay Bagga, Stanley Silverman. Sandwell West Birmingham
Hospitals NHS Trust, City Hospital, Birmingham, UK.
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ABSTRACTSIntroduction: An initial study demonstrated signiﬁcantly increased risk of
malignant diagnosis in those aged 60 or over diagnosed with idiopathic
venous thrombo-embolism. This follow up survey investigate whether fast
track pathways screen for potential malignancy in idiopathic deep venous
thrombosis (DVT).
Methods: A telephone survey contacted all hospital medical trusts
advertising in a single edition of the BMJ careers. The survey identiﬁed
trusts’ use of fast-track pathways for DVT, whether nurse led, physician
involvement and follow up procedures for idiopathic cases.
Results: 52 trusts responded (91%). All trusts conducted some form of
rapid access fast track pathway for DVT referral and investigation. 47 (94%)
used nurse led pathways, 46 (88%) had little or no physician contact once
referred to the pathway. Of 52 responses, 2 (3.6%) had formal guidelines for
in-depth assessment of patients labelled idiopathic aged 60 or over by a
physician.
Conclusions: Fast-track DVT pathways require greater physician input to
screen cases, looking for possible occult malignancy as an underlying cause
for VTE. Current moves to community based nurse led pathways may
result in a missed opportunity to diagnose and intervene in malignancy at
an earlier stage.
0070: UPTAKE OF CAROTID ARTERY STENTING IN ENGLAND AND SUB-
SEQUENT VASCULAR ADMISSIONS: AN APPROPRIATE RESPONSE TO
EMERGING EVIDENCE?
Angeline Hwee Yin Lee 1, John Busby 1, Marcus J. Brooks 2,
William Hollingworth 1. 1University of Bristol, Bristol, UK; 2Bristol Royal
Inﬁrmary, Bristol, UK.
Aims:We report the uptake, length of stay and vascular readmission rates
of carotid endarterectomy (CEA) and carotid artery stenting (CAS) in the
English National Health Service (NHS) between 2006 and 2009.
Methods: This is a retrospective cohort study based on Hospital Episode
Statistics (HES) inpatient data on CEA (n¼15996) and CAS (n¼632). We
analysed trends in procedure use over time and used ordinary least
squares multivariate analysis and Cox proportional hazards regressions to
evaluate patient, clinical and organisational characteristics associated with
longer length of stay for revascularisation and higher rates of readmission
for vascular events.
Results: CASmade up less than 5% of carotid revascularisation procedures;
there was no trend for increasing use over time. CAS patients had a 35%
(95% CI: 30, 39) shorter stay in hospital than CEA patients. However they
were more likely to be readmitted following stroke, transient ischaemic
attack (hazard ratio 1.52 [95% CI: 1.19, 1.94]) and myocardial infarction
(hazard ratio 1.54 [95% CI: 1.08, 2.21]).
Conclusions: Despite the early promise of CAS and numerous RCTs eval-
uating efﬁcacy, it has not been rapidly adopted in England. Cautious
adoption may be appropriate given the ﬁnely balanced evidence regarding
subsequent myocardial infarction, stroke and cost-effectiveness.
0087: LAPAROSCOPIC LIGATION OF TYPE II ENDOLEAKS POST ENDO-
VASCULAR ANEURYSM REPAIR (EVAR): CURRENT EVIDENCE FOR PRAC-
TICE e A SYSTEMATIC REVIEW
Thomas Marjot 1, Andrew Choong 1, Kirtan Patel 2, Vamsee Bhrugubanda 2,
Stuart Gould 3, Sophie Renton 1. 1Outer North West London Regional Vascular
Unit, Northwick Park Hospital, London, UK; 2 Imperial College School of
Medicine, London, UK; 3Department of General Surgery, Northwick Park
Hospital, London, UK.
Aims: Type II endoleak complicates 10-25% of EVAR. Although the clin-
ical signiﬁcance of type II endoleak remains contentious, the strategies
used for its management have continued to expand. We systematically
review the literature and comprehensively appraise the effectiveness of
laparoscopic intervention in the management of this common
complication.
Methods: Review methods were according to the Preferred Reporting
Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines.
Published literature from ﬁve electronic databases was searched.
Studied outcomes included patient demographic, aneurysm type,
graft type, endoleak type, previous endovascular embolization
attempted, vessel ligated laparoscopically, length of stay and follow
up duration.Results: 9 studies representing 20 patients were investigated. Mean age
was 74.4. All patients were ASA II and above. All underwent standard
infrarenal EVAR. 16 patients suffered a type II endoleak from the inferior
mesenteric artery. 60% (12/20) patients had unsuccessful or were unsuit-
able for embolization. 30-day mortality was 5%.
Conclusions: Direct laparoscopic ligation of feeding vessels causing type II
endoleak is particularly useful in cases where standard endovascular
embolization has failed. It is associated with low 30-day mortality and
should be considered an essential tool in the armamentarium of the
vascular and laparoscopic surgeon.
0095: PROFILING OF MOISTURE STATUS IN VENOUS LEG ULCERS
Joshua Burke 1, Mustafa Khanbhai 2, Charles McCollum 2,
Patricia Connolly 3, Eileen Temple 3. 1University of Manchester, Manchester,
UK; 2Univeristy Hospital of South Manchester, Manchester, UK; 3Ohmedics,
Glasgow, UK.
Aims: The aim of this study was to assess wound moisture levels and to
evaluate correlation with Venous Leg Ulcer (VLU) healing.
Methods: Seven patients were recruited over 21 days and their VLUs were
classiﬁed; class A (healthy, healing) to class D (unhealthy, not healing).
Ulcer moisture levels were recorded bi-weekly using a non-invasive
wound moisture monitoring system [dry(1) to wet(4)] without disturbing
compression regimes. Digital Planimetry calculated healing rate (% change
in ulcer size/week).
Results: Mean (+SEM) age was 72 years (+ 4.3). By day 21, 57% (n¼4) of
patients with VLUs had completely healed. Class A ulcer was 100% predic-
tive of 100% granulation and ‘drop' reading of 1. There was correlation be-
tween ulcers with greater surface area and higher moisture levels rs¼0.4,
p<0.05. However, ulcers with a faster healing rate (40%) had greater
moisture content compared to slower-healing ulcers (<40%), p<0.05.
Conclusions: We have demonstrated that moisture content may play a
role in VLU healing rate. Class A ulcers correlate well with moisture and
granulation, indicating; dry readings are found at complete granulation/
healing. Further work is required to elucidate whether artiﬁcially
increasing VLU moisture content has a role in hastening healing in class C,
D and slow-healing ulcers.
0098: THE OUTCOME OF ENDOVASCULAR TREATMENT FOR COMPLI-
CATED ACUTE DISSECTION IS DEPENDENT UPON TREATMENT INDICA-
TION: THE NEED FOR CLEAR GUIDELINES
Elizabeth Rajiah 2, Rachel E. Clough 1, Kevin Mani 1, Susie Key 1,
Tarun Sabharwal 1, Richard Salter 1, Irfan Ahmed 1, Andrew McGrath 1,
Panos Gkoutzious 1, Peter Taylor 1. 1Guy's & St Thomas's NHS Foundation
Trust, London, UK; 2King's College London, London, UK.
Objective: Thoracic endovascular aortic repair (TEVAR) is the treatment of
choice for complicated acute type B dissection. However the indications for
intervention vary widely in their severity. We investigated the effect of
treatment indication on outcome.
Methods: All patients treated for acute complicated type B dissection at a
tertiary referral centre between January 2000-July 2011 were identiﬁed
froma prospective TEVAR database. Patientswere categorised based on the
indication for treatment: rupture, end organ ischaemia and persistent pain.
Death, stroke and paraplegiawere regarded asmajor adverse events (MAE).
Results: 43 patients were identiﬁed. The perioperative rate of MAEs was
27.9% (death 11.6%, stroke 11.6%, paraplegia 9.3%). The MAE rate was 25.0%
for those treated for rupture, 46.7% for end organ ischaemia and 8.3% for
persistent pain. Persistent pain as an indication was associated with a
better outcome compared with end organ ischaemia (p¼0.04) but not
compared with aortic rupture (p¼0.36).
Conclusion: Treatment indication affects the outcome of TEVAR for
complicated type B aortic dissection. Patients with persistent pain have a
better outcome than those with end-organ ischaemia. The mode of pre-
sentation and treatment indication should be used for risk stratiﬁcation of
patients with complicated acute type B aortic dissection.
0112: TEMPORAL ARTERY BIOPSIES: ARE WE TAKING LONG ENOUGH
SPECIMENS?
Ashok Gunawardene, Harvey Chant. Royal Cornwall Hospital, Truro, UK.
Introduction: Temporal artery biopsy is the "gold standard" investigation
for giant cell arteritis. The Royal College of Rheumatologists guidelines
